Centeril

Centeril® is a food supplement based on Boswellia, Hesperidin, Vitamin C, Blueberry, Dandelion and Sweet Clover. Vitamin C supports normal collagen formation and normal blood vessel function.

Therapeutic areas

Centeril®, with its unique composition, is an effective help in cases of both acute and chronic venous insufficiency.

 

The anti-oedema effect of Centeril® induces an improvement in the trophism

of the microcirculation, restoring vascular homeostasis, enhancing the lymphatic pump with consequent reduction of stasis oedema.

A daily intake of Centeril® is therefore particularly effective in cases of:

  • Venous insufficiency
  • Capillary fragility
  • Microcirculation disorders
  • Stasis oedema

Take one tablet per day. Swallow with water.

Centeril® tri-layer tablets work by innovative Fast-Slow technology,

which modulates the release of the substances contained in the formulation:

Layer 1 – action with immediate benefits and “anti-inflammatory” activity – FAST

release: Boswellia serrata dry extract.

Layer 2 – action on the microcirculation with similar Vitamin P activity – SLOW release:

Blueberry dry extract titrated in 1% anthocyanins, Vitamin C, Hesperidin.

Layer 3 – anti-oedema/detoxifying action – PROLONGED release: sweet clover dry extract,

Titrated dry extract of dandelion. 2%.

The characteristic pigmentation of the tablet is due to the presence of

plant extracts.

Store in a cool and dry place, away from light or local heat sources, sunlight, and avoid contact with water.

Do not exceed the recommended daily dose. Food supplements are not

intended to be a substitute for a varied, balanced diet and a healthy lifestyle. The

expiry date refers to the product correctly stored in unopened packaging.

KEEP OUT OF THE REACH OF CHILDREN UNDER THREE YEARS

GLUTEN AND LACTOSE FREE

Substances with a nutritional or physiological effectPer daily dose*VNR%
Blueberry150 mg
Boswellia 100 mg
Dandelion100 mg
Vitamin C80 mg100
Melilotus75 mg
Hesperidine25 mg

*VNR: Nutrient Reference Values in accordance with EU Reg. 1169/2011